home.social

#biopharma — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biopharma, aggregated by home.social.

  1. Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

    Toronto, Ontario–(Newsfile Corp. – September 15, 2026) – Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma”…
    #Canada #Toronto #arcstonekingswood #Attend #Biopharma #growth #quantum #Summit
    europesays.com/canada/210378/

  2. Korea’s SK Biopharmaceuticals partners with Biohaven for epilepsy treatment

    Korea’s SK Biopharmaceuticals partners with Biohaven for epilepsy treatment August 26, 2026 | Wednesday | News SK Biopharmaceuticals…
    #EuropeSays #Korea #KR #SK #Biopharma #Epilepsy #FDA #medicine #SKGroup
    europesays.com/korea/133207/

  3. Novotech Strengthens Japan Presence with New Tokyo Office » World Business Outlook

    Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan…
    #EuropeSays #Japan #JP #Business #Biopharma #biotechnology #BusinessofJapan #ClinicalTrials #CRO #healthcare #innovation #Japan'sbusiness #Japanesebusiness #NovoTech #pharma #Research #Tokyo #WBO
    europesays.com/japan/79204/

  4. GSK’s Blenrep combinations approved in Singapore for relapsed or refractory multiple myeloma

    GSK’s Blenrep combinations approved in Singapore for relapsed or refractory multiple myeloma August 21, 2026 | Friday |…
    #EuropeSays #Britain #Europe #EU #GSK #antibodydrugconjugate #BCMA #belantamabmafodotin #biopharma #Blenrep #DREAMM-7 #DREAMM-8 #HSASingapore #multiplemyeloma #Oncology #relapsedmultiplemyeloma
    europesays.com/britain/108040/

  5. AI Drug Purification Clears GMP Test at Taiwan CDMO: 11 Percent Recovery Gain From Five Experiments

    Jeff Wang, Cytiva’s Business Head of Taiwan, and Dr. Pei-Jiun Chen, CEO and President of Mycenax Biotech, poured…
    #Conflict #Conflicts #War #AI #Biopharma #BIOSECUREAct #CDMO #China #ChinaTaiwanConflicts #GMP #GoSilico #MycenaxBiotech #Taiwan
    europesays.com/3174456/

  6. EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women’s Health Drug Approval

    Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory approval to introduce its 2mg generic…
    #Canada #Biopharma #Canadianmarket #genericequivalent #progesteronereceptors #regulatoryapproval
    europesays.com/canada/155120/

  7. Sanofi lifts 2026 outlook after strong Q2 growth | SNY SEC Filing

    Washington, D.C. 20549 Indicate by check mark whether the registrant files or will file annual reports under cover…
    #France #FR #Europe #EU #Sanofi #2026guidance #biopharma #businessEPS #Dupixentsales #FreeCashFlow #pharmaearnings #quarterlyresults #SNY #vaccines
    europesays.com/france/59683/

  8. Sanofi revamps leadership, halts amlitelimab in AD | SNY SEC Filing

    Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY. Sanofi Media Relations Sandrine Guendoul | +33 6 25…
    #France #FR #Europe #EU #Sanofi #2026guidance #amlitelimabdiscontinuation #atopicdermatitis #biopharma #celiacdiseasetrial #executivecommitteechanges #Form6-K #R&Dpipeline #SNY
    europesays.com/france/57434/

  9. Sanofi posts positive Nexviazyme phase 3 IOPD data | SNY SEC Filing

    About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling…
    #France #FR #Europe #EU #Sanofi #Baby-COMET #biopharma #enzymereplacementtherapy #infantile-onsetPompe #labelextension #Nexviazyme #phase3trial #Pompedisease #SNY
    europesays.com/france/47935/

  10. NEW: Anthropic buried the lede in its Claude Science event today: It's going to start developing its own drugs.

    Details are scarce, but @matthewherper and I talked to Anthropic executives to bring you some exclusive tidbits about the program:

    statnews.com/2026/06/30/anthro

    #health #healthcare #medicine #biotech #pharma #biopharma #drugdevelopment #AI #artificialintelligence #claude #anthropic

  11. NEW: Anthropic buried the lede in its Claude Science event today: It's going to start developing its own drugs.

    Details are scarce, but @matthewherper and I talked to Anthropic executives to bring you some exclusive tidbits about the program:

    statnews.com/2026/06/30/anthro

    #health #healthcare #medicine #biotech #pharma #biopharma #drugdevelopment #AI #artificialintelligence #claude #anthropic

  12. NEW: Anthropic buried the lede in its Claude Science event today: It's going to start developing its own drugs.

    Details are scarce, but @matthewherper and I talked to Anthropic executives to bring you some exclusive tidbits about the program:

    statnews.com/2026/06/30/anthro

    #health #healthcare #medicine #biotech #pharma #biopharma #drugdevelopment #AI #artificialintelligence #claude #anthropic

  13. NEW: Anthropic buried the lede in its Claude Science event today: It's going to start developing its own drugs.

    Details are scarce, but @matthewherper and I talked to Anthropic executives to bring you some exclusive tidbits about the program:

    statnews.com/2026/06/30/anthro

    #health #healthcare #medicine #biotech #pharma #biopharma #drugdevelopment #AI #artificialintelligence #claude #anthropic

  14. NEW: Anthropic buried the lede in its Claude Science event today: It's going to start developing its own drugs.

    Details are scarce, but @matthewherper and I talked to Anthropic executives to bring you some exclusive tidbits about the program:

    statnews.com/2026/06/30/anthro

    #health #healthcare #medicine #biotech #pharma #biopharma #drugdevelopment #AI #artificialintelligence #claude #anthropic

  15. Lilly, Samsung Biologics to Build Songdo Biotech Hub

    ‘LGL Incheon’ to be completed in July next year… 30 tenant companies to be jointly selected by…
    #EuropeSays #Korea #KR #SamsungBiologics #Biopharma #K-FOCUS #Samsung
    europesays.com/korea/69623/

  16. europesays.com/britain/59928/ GSK to buy Boston-based biopharma firm Nuvalent for $10.6bn #$106bn #biopharma #BostonBased #Category:All #Category:CompanyNews #Category:HeadlineNews #Category:M&A #Category:MarketPulse #Category:MarketReport #Category:NewsAndAnnouncements #Category:Sectorial:HealthTechnology #firm #GSK #Nuvalent

  17. Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents

    A 3D rendering of a biological cell from the company’s homepage, where it animates to reveal layers of…
    #France #FR #Europe #EU #Sanofi #AgenticAI #artificialintelligence #biopharma #biotechnology #ClinicalTrials #drugdiscovery #KPro #MCPservers #multimodaldata #Oncology #Owkin #OwkinZero
    europesays.com/france/31377/